This is good news.... Maybe the detail is in what the doctor said. Direct injections = 80% healing rate, which is rather high !
They have been using these cells for a while in hospitals in Australia with success too, so I wouldn't say necessarily that the IV route failed to have an effect...
What they may find, with direct injection they may get away with significantly less cells needed = lower cost of therapy = more competitive.
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis
MSB
mesoblast limited
Add to My Watchlist
0.91%
!
$1.67

Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis, page-50
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.67 |
Change
0.015(0.91%) |
Mkt cap ! $2.121B |
Open | High | Low | Value | Volume |
$1.65 | $1.67 | $1.63 | $3.655M | 2.203M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 48000 | $1.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.67 | 100315 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 48000 | 1.660 |
4 | 12654 | 1.655 |
9 | 125134 | 1.650 |
2 | 16000 | 1.640 |
2 | 49999 | 1.635 |
Price($) | Vol. | No. |
---|---|---|
1.670 | 125595 | 9 |
1.675 | 61655 | 11 |
1.680 | 9000 | 3 |
1.685 | 8000 | 3 |
1.690 | 29706 | 6 |
Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |